13D Filing: Longwood Fund II, L.P. and Kalvista Pharmaceuticals Inc. (KALV)

Names of
Reporting Persons.

Longwood Fund II, L.P.
(LFII)

Check the Appropriate Box if a Member
of a Group (See Instructions)

(a)  ☐        (b)  ☒

SEC Use Only

Source of Funds (See Instructions)

WC

Check if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e)  ☐

Citizenship or Place of
Organization

Delaware

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With

Sole Voting Power

934,484 shares, except that (i) Longwood Fund II GP, LLC (LFII GP), the
general partner of LFII, may be deemed to have sole power to vote these shares, and (ii) Christoph Westphal, M.D., Ph.D. (Westphal), a manager and member of LFII GP, may be deemed to have shared power to vote these shares, and Richard
Aldrich (Aldrich), a manager and member of LFII GP and a member of the Board of Directors of the Issuer, may be deemed to have shared power to vote these shares.

Shared Voting Power

See response to row 7.

Sole Dispositive Power

934,484 shares, except that (i) LFII GP, the general partner of LFII, may be deemed to
have sole power to dispose of these shares, and (ii) Westphal, a manager and member of LFII GP, may be deemed to have shared power to dispose of these shares, and Aldrich, a manager and member of LFII GP and member of the Board of Directors of the
Issuer, may be deemed to have shared power to dispose of these shares.

Shared Dispositive Power

See response to row 9.

Aggregate Amount Beneficially Owned by Each Reporting Person

934,484

Check if the Aggregate Amount in Row
(11) Excludes Certain Shares (See Instructions)  ☐

Percent of Class Represented by Amount
in Row (11)

8.7%*

Type of Reporting Person (See
Instructions)

PN